Frank Lamberti Sells 134,982 Shares of Herbalife (NYSE:HLF) Stock
by Scott Moore · The Cerbat GemHerbalife Ltd (NYSE:HLF – Get Free Report) insider Frank Lamberti sold 134,982 shares of the firm’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $13.50, for a total value of $1,822,257.00. Following the sale, the insider owned 36,624 shares of the company’s stock, valued at $494,424. The trade was a 78.66% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link.
Herbalife Price Performance
HLF traded up $0.11 during trading on Tuesday, reaching $13.62. 1,901,331 shares of the stock traded hands, compared to its average volume of 1,312,022. The stock has a market cap of $1.41 billion, a price-to-earnings ratio of 5.98, a price-to-earnings-growth ratio of 0.80 and a beta of 0.98. Herbalife Ltd has a fifty-two week low of $6.62 and a fifty-two week high of $20.40. The stock’s 50-day simple moving average is $15.58 and its two-hundred day simple moving average is $14.38.
Herbalife (NYSE:HLF – Get Free Report) last released its quarterly earnings data on Wednesday, May 6th. The company reported $0.64 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.61 by $0.03. Herbalife had a negative return on equity of 41.47% and a net margin of 4.67%.The firm had revenue of $1.32 billion during the quarter, compared to analysts’ expectations of $1.30 billion. During the same quarter last year, the firm earned $0.59 earnings per share. The business’s revenue for the quarter was up 7.8% on a year-over-year basis. Research analysts anticipate that Herbalife Ltd will post 2.47 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
A number of research firms have recently commented on HLF. Weiss Ratings reiterated a “hold (c+)” rating on shares of Herbalife in a research note on Friday. Citigroup reiterated a “buy” rating and issued a $21.00 price objective (up from $17.00) on shares of Herbalife in a research note on Thursday, February 19th. Zacks Research lowered Herbalife from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 20th. Mizuho set a $17.00 price objective on Herbalife in a report on Monday, May 4th. Finally, Wall Street Zen raised Herbalife from a “buy” rating to a “strong-buy” rating in a report on Saturday, April 18th. Three investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $17.80.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently modified their holdings of HLF. Dimensional Fund Advisors LP lifted its holdings in Herbalife by 29.3% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,877,717 shares of the company’s stock worth $27,638,000 after buying an additional 425,968 shares in the last quarter. KBC Group NV acquired a new position in Herbalife during the 1st quarter worth $44,000. Principal Financial Group Inc. acquired a new position in Herbalife during the 1st quarter worth $1,809,000. Sequoia Financial Advisors LLC bought a new stake in shares of Herbalife during the 1st quarter valued at $152,000. Finally, Summit Securities Group LLC bought a new stake in shares of Herbalife during the 1st quarter valued at $299,000.
Herbalife Company Profile
Herbalife Nutrition Ltd. (NYSE: HLF) operates as a global multi-level marketing company specializing in weight-management, nutritional supplement, sports nutrition and personal care products. Its portfolio includes protein shakes, vitamins, energy and fitness supplements, hydration products and skin and hair care items, all formulated to support wellness, performance and healthy living. Products are manufactured in GMP-certified facilities to ensure consistent quality and safety standards.
Founded in 1980 by Mark R.